The group’s principal activity is to provide pharmaceutical drugs in treatment of human aging and age associated disease. The group's products include Telomeres, Synthetic DNA Nanocircles, PLGA Biodegradable Nanoparticles, oTrt, Notch 1, and Mitofusin 1. The group operates from Europe and the United States.
